Compounds > zalcitabine
Page last updated: 2024-08-22

zalcitabine and AIDS Dementia Complex

zalcitabine has been researched along with AIDS Dementia Complex in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horwitz, JP; Kessel, D; Meltsner, BR; Palomino, E1
Abdul, HM; Ansari, MA; Butterfield, DA; Nath, A; Opii, WO; Sultana, R1
Portegies, P1
Baldeweg, T; Catalan, J; Gazzard, BG1
Böckenholt, S; Evers, S; Frese, A; Frohne, L; Heese, C; Husstedt, IW; Rahmann, A; Reichelt, D1

Trials

2 trial(s) available for zalcitabine and AIDS Dementia Complex

ArticleYear
Impact of highly active antiretroviral therapy on cognitive processing in HIV infection: cross-sectional and longitudinal studies of event-related potentials.
    AIDS research and human retroviruses, 2002, May-01, Volume: 18, Issue:7

    Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cross-Sectional Studies; Didanosine; Drug Therapy, Combination; Evoked Potentials; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Treatment Outcome; Zalcitabine; Zidovudine

2002
FDA expands testing of anti-AIDS drugs.
    New York state journal of medicine, 1989, Volume: 89, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Complex; Antiviral Agents; Clinical Trials as Topic; Didanosine; Humans; Infant; Infant, Newborn; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine

1989

Other Studies

4 other study(ies) available for zalcitabine and AIDS Dementia Complex

ArticleYear
Synthesis and in vitro evaluation of some modified 4-thiopyrimidine nucleosides for prevention or reversal of AIDS-associated neurological disorders.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:1

    Topics: AIDS Dementia Complex; Animals; Antiviral Agents; Cell Line; Chemical Phenomena; Chemistry; Chemistry, Physical; Cytopathogenic Effect, Viral; Dideoxynucleosides; HIV; Humans; Kinetics; Molecular Structure; Phosphorylation; Pyrimidine Nucleosides; Rabbits; Stavudine; T-Lymphocytes; Thymidine Kinase; Thymus Gland; Zidovudine

1990
Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementia.
    Experimental neurology, 2007, Volume: 204, Issue:1

    Topics: AIDS Dementia Complex; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Bridged-Ring Compounds; Caspase 3; Cerebral Cortex; Cytochromes c; Disease Progression; Gerbillinae; Humans; Lamivudine; Male; Mitochondria; Nerve Tissue Proteins; Neuroprotective Agents; Norbornanes; Oxidation-Reduction; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Inhibitors; Synaptosomes; Thiocarbamates; Thiones; Tyrosine; Zalcitabine

2007
HIV-1, the brain, and combination therapy.
    Lancet (London, England), 1995, Nov-11, Volume: 346, Issue:8985

    Topics: Adult; AIDS Dementia Complex; Antiviral Agents; Child; Didanosine; Drug Combinations; HIV-1; Humans; Lamivudine; Neuroprotective Agents; Stavudine; Zalcitabine; Zidovudine

1995
Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.
    Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 65, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Brain Diseases; Didanosine; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Retrospective Studies; Risk; Stavudine; Treatment Outcome; Zalcitabine; Zidovudine

1998